Efficacy and Practical Use of Efinaconazole for Fingernail Onychomycosis

Efficacy Data

The British Association of Dermatologists (BAD) 2014 guideline reports that efinaconazole 10 % topical solution achieves mycological cure in approximately 50 % of patients and complete clinical cure in about 15 % after 48 weeks of daily application to affected nails, including fingernails. 1
According to BAD 2014, fingernail onychomycosis generally responds better to treatment than toenail disease because fingernails grow faster and allow superior drug penetration. This observation is supported by two 2003 British Journal of Dermatology studies. [2][3]

Systemic antifungal therapy (terbinafine 250 mg daily for 6 weeks or itraconazole) is more effective than any topical regimen for onychomycosis; topical efinaconazole requires 24–48 weeks to achieve comparable outcomes. This recommendation is derived from BAD 2014 guidance. 1
Efinaconazole’s minimal systemic absorption results in virtually no drug‑drug interactions, a benefit highlighted in the 2003 British Journal of Dermatology safety analysis. 2

BAD 2014 advises that no nail filing or debridement is necessary before applying efinaconazole 10 % solution to fingernails, simplifying the treatment protocol. 1
For fingernail onychomycosis, the recommended regimen is once‑daily application of the solution to the entire nail plate, nail bed, hyponychium, and any accessible undersurface for a minimum of 24 weeks and up to 48 weeks, reflecting the shorter treatment duration relative to toenails. 1

Baseline liver‑function testing is not required when using efinaconazole, unlike oral antifungal agents; this guidance is provided in the BAD 2014 guideline. 4

Clinical improvement with efinaconazole often exceeds mycological cure; the BAD 2014 guideline notes that mycological cure rates are typically about 30 % lower than observed clinical improvement, underscoring the need for confirmatory mycological testing at therapy completion. 1